ArticleScientific reports2021
Comparing right- and left sided injection-drug related infective endocarditis.
Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.
- Valve involvement in infective endocarditis among intravenous drug users: a systematic review and meta-analysis.BMC infectious diseases · 2026Pooled it
- Percutaneous Mechanical Aspiration of Left-Sided Intracardiac Masses for Prohibitive Surgical Candidates: A Single-Center Experience.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Article
- Prosthetic Aortic Valve Vegetation: A Percutaneous Mechanical Aspiration Approach.JACC. Case reports · 2026Article
- Comparative effectiveness of adjunctive rifampicin versus gentamicin for prosthetic valve endocarditis due toJAC-antimicrobial resistance · 2025Article
- Antibiotic treatment duration for isolated methicillin-susceptibleJAC-antimicrobial resistance · 2025Article
- Clinical features and outcomes of infective endocarditis in persons experiencing homelessness.Infectious diseases of poverty · 2025Article
- Bilateral valvular involvement in infective endocarditis: A clinically distinct entity? A multicenter retrospective study.PloS one · 2025Article
- Infective endocarditis in a Finnish tertiary care hospital: from etiology to embolic events.Annals of medicine · 2024Article
- Left-sided infective endocarditis presenting with pulmonary involvement and liver abscess: A case report.Clinical case reports · 2024Article
- A rare Serratia marcescens-associated acute endocarditis of a tricuspid valve in an intravenous drug user : A case report and literature review.Wiener klinische Wochenschrift · 2023Review
- Prevalence of Right- and Left-Sided Endocarditis Among Intravenous Drug Use Patients at a Large Academic Medical Center.Cardiology research · 2023Article
- Characteristics and outcomes of angiovac-assisted debulking of intracardiac masses, thrombi, and endocarditis.Clinical research in cardiology : official journal of the German Cardiac Society · 2023Article
- Five-Year Cardiovascular Outcomes after Infective Endocarditis in Patients with versus without Drug Use History.Journal of personalized medicine · 2022Article
- Serratia Marcescens, a Rare and Devastating Cause of Endocarditis: A Case Report and Review of the Literature.Cureus · 2022Article
- Rupture of Both Left-Sided Valves Following Endocarditis Causing One Trouble After Another: A Case Report.Cureus · 2022Article
- Surgery Is Underused in Elderly Patients With Left-Sided Infective Endocarditis: A Nationwide Registry Study.Journal of the American Heart Association · 2021Article
- Acute drug-use-related native tricuspid valve infective endocarditis: a non-surgical disease.Therapeutic advances in infectious diseaseReview
- Endovascular treatment of infectious intracranial aneurysms: A single-center experience.Brain circulationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of the study was to compare background characteristics, microbiology and outcome of patients with right-sided and left-sided intravenous drug use (IDU) associated infective endocarditis (IE). A nationwide retrospective study using the Swedish Registry on Infective Endocarditis between 2008 and 2019 was conducted. A total of 586 people with IDU-IE were identified and divided into left-sided (n = 204) and right-sided (n = 382) IE. Descriptive statistics, Cox-regression and Kaplan-Meier survival estimates were used. The mean age of patients in the left-sided group was 46 years compared to 35 years in the right-sided group, p < 0.001. Left-sided IE had a higher proportion of females. Staphylococcus aureus was the causative pathogen in 48% of cases in the left-sided group compared to 88% in the right-sided group. Unadjusted and adjusted long-term survival was better in right-sided IE compared to left-sided IE. Independent predictors of long-term mortality were increasing age, end-stage renal disease, nosocomial infection, brain emboli and left-sided IE. Left-sided IE was common in people with IDU but the proportion of females with left-sided IE was low. S. aureus was twice as common in right-sided IE compared to left-sided IE, and the long-term prognosis of right sided IDU-associated IE was better compared to left-sided IE despite the fact that few were operated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.